Nissha Medical Technologies (NMT) the medical devices business unit of Japan’s Nissha Co. Ltd., has officially opened its new Nashville Innovation Center of Excellence with a ribbon-cutting ceremony on Vanderbilt University’s main campus. The company says the event marks the completion of a major re
“Even if you don’t realise your device is considered radio equipment, it probably is.” In our latest Meet the Speakers interview, Alexander Toohie, Technical Solution Manager at Element Materials Technology, previews his Med-Tech Expo conference session, where he will shed light on a frequently over
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, predicts business as usual for the newly appointed Health Secretary. The Rt Hon James Murray MP has been appointed as Secretary of State for Health and Social Care. Murray pr
“Blurred Lines: When Medical Devices Fall Between Regulatory Definitions” In the latest instalment of our Med-Tech Expo 2026 “Meet the Speakers” series, we spoke to Bethany Dean from Taylored Consultancy for a preview of her upcoming conference session at Med-Tech Expo. If you want to navigate the c
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, notes the resignation of the Health Secretary in order to challenge Keir Starmer as Prime Minister and Leader of the Labour Party. In a statement posted on X, Wes Streeting h
Cell and Gene Therapy Catapult (CGT Catapult) will provide investment to Lir Therapeutics (Lir) from the Innovate UK Cross Catapult Investment Pilot, to accelerate the development of nAAVigator, its AI-driven AAV capsid design platform. The investment will support Lir in advancing the biological val
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, calls for urgent clarification on the approach of England’s NHS supply giant to value-based procurement and warns that government ministers may be being misled. A recent, suc
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, updates readers on moves by the medical devices regulator to collaborate with Northern Ireland’s MedTech sector. The UK’s Medicines and Healthcare products Regulatory Agency
Calla Lily Clinical Care, a women’s health-focused medical technology company, has announced dosing of the first patients in the FREEDOM clinical trial. The study, funded by the National Institute for Health and Care Research (NIHR), is evaluating 400mg progesterone Callavid in patients diagnosed wi
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, hopes the new MedTech Minister will proceed at full speed with the roll-out of value-based procurement. The Prime Minister, Sir Keir Starmer, has appointed Preet Kaur Gill MP
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, regrets the resignation of Dr Zubir Ahmed, government minister responsible for MedTech. The Government minister responsible for medical technology and innovation, Dr Zubir Ah
“Regulatory Strategy as a Growth Lever: What UK and EU Assessors and Investors Expect” We spoke to Benyamin Rahmani, PhD from MedStride for a preview of his upcoming conference session at Med-Tech Expo. If you want to stop viewing regulatory as a “compliance exercise” and start using it as a strateg
